IndraLab

Statements

USP22 binds CD101. 3 / 3
| 3
sparser
"This Study demonstrated that targeting PCBP1-AS1 increases the sensitivity of prostate cancer cells to Enzalutamide by reducing the binding of USP22 to AR-V7 or AR and decreasing the stability of the complex, providing new ideas for the clinical treatment of drug-resistant patients with CRPC."
39655078
sparser
"Collectively, nobiletin selectively induces AR-V7 degradation by inhibiting the interaction of AR-V7 with USP22."
35935969
sparser
"Binding of USP22 to AR-V7 prevents AR-V7 protein degradation."
35935969